Thymol
The primary olfactory and tactile irritant, with a long history of aromatic use.
Technology · MED 017
Chemosensory design.
Not toxic force.
MED 017 is an advanced insect-repellent platform built from green active ingredients. It changes pest behavior instead of relying on lethal chemistry.
Low resistance pressureWater basedPollinator consciousThe formulation
Four familiar elements.
A protected composition.
Scientifically validated, flavor-derived ingredients are combined to repel a broad vector of harmful insects while preserving vital biodiversity.
Vanillin
A flavor-derived aromatic aldehyde within the protected active system.
Alkyl-diol
A complementary component supporting the repellent formulation.
Water
The practical carrier that makes adoption familiar and scalable.
Mechanism
From signal
to separation.
Sensory signal
Thymol and complementary green actives engage olfactory and tactile pathways insects use to locate a host.
Repellent response
The formulation creates an environment pests avoid rather than a lethal exposure that selects survivors.
Operational fit
A water-based concentrate integrates with established tank-mix, spray and IPM routines.
Ecological continuity
Non-lethal control preserves residual insect populations that support pollinators and food chains.
A different profile
Durable control,
without the usual trade-offs.
MED 017 is designed to complement existing pest management while reducing the operational and ecological friction associated with lethal chemistry.
MED 017 approachConventional lethal chemistry
Non-lethal; minimal resistance pressureSelection pressure can shorten useful life
Non-systemic; no meat or milk residues per product positioningResidue and withdrawal constraints may apply
Supports continuous productionOperational downtime may be required
Preserves pest-population balanceBroad insect removal can disrupt ecosystems
Validation
Performance that improves after application.
In the supplied stable-cattle study, treated-group tick counts diverged from the control after day three and continued downward through day fourteen.
Source noted in the management presentation: Sustainable Science Vet preclinical efficacy study; principal investigator Dr. Rafael Paranhos de Mendonça.
Intellectual property
Protected across markets.
EP EP3876719A1US US20210400960A1MA MA54140APCT WO2025073872A1
Product claims, indications and development milestones reflect the supplied management materials and remain subject to local registration, label and regulatory requirements.